The Albanese Labor Government is delivering its pledge to expand biomanufacturing capabilities in Queensland with a $12.6 million investment in Cytiva’s Springfield BioPark Australia project.
The Biopark project in Ipswich will help the Queensland-based company purchase new equipment that would boost its biomanufacturing capabilities for high-value medicines.
“The Albanese Government was elected with a mandate to revitalise Australian manufacturing, with a strong focus on supporting regional development,” said Minister for Industry and Science Ed Husic.
Federal Member for Blair Shayne Neumann commended the Albanese government’s move to back the Springfield Biopark project, which he said will boost advanced manufacturing of critical therapies and vaccines and support local jobs in Ipswich.
“The Springfield BioPark will be a real game-changer with so many benefits for Ipswich and Queensland,” Neumann said.
The Springfield BioPark Australia project will boost Australia’s sovereign capability in medical manufacturing, including mRNA vaccine production, which will support Australia’s future pandemic preparedness.
“I’ve made clear I want to drive advanced manufacturing in Greater Springfield – to bring business and community together to boost investment and jobs in the region, so I’m proud to see this commitment delivered by the Federal Government,” said Federal Member for Oxley Milton Dick.
The $12.6 million investment is one of eight targeted industry grants the Albanese government delivered in the Budget to support local industry, economic growth, and job creation.
